Cooperative Agreement NU58DP006105

This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $697,198 to the University of California, San Diego (UCSD) to develop a targeted colorectal cancer (CRC) screening strategy for adults aged 45-49. The study aims to: 1) characterize the acceptability of CRC screening in this age group and identify factors influencing screening uptake; and 2) conduct a randomized controlled trial to compare...

The Puerto Rico Department of Health (PRDOH) has been awarded a $4,441,646 five-year Cooperative Agreement (NU51CK000381) by the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421). This federal grant award will enhance PRDOH's epidemiology and laboratory capacity to control, prevent, and mitigate infectious diseases in the Puerto Rico...

This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $197,640 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop implementation strategies to initiate colorectal cancer (CRC) screening in previously unscreened individuals aged 45 to 54 at a predominantly Black community health center in Boston, Massachusetts. The key objectives are to: (1) identify system-level determinants of...

This federal Project Grant award of $622,913 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will fund a 5-year study to evaluate a multilevel intervention to increase colonoscopic follow-up after abnormal stool-based colorectal cancer screening in a community safety-net setting. The study will be conducted by the University of California, Los Angeles (UCLA) in partnership with the Northeast Valley Health Corporation (NEVHC), a...

The National Cancer Institute awarded a $5,151,564 Project Grant under the Cancer Centers Support Grants (CFDA 93.397) program to the Fred Hutchinson Cancer Center in Seattle, WA. The funding supports a Translational Research Program in Colorectal Cancer Disparities (TRPCD) that aims to improve risk-stratified screening, reduce disparities in colorectal cancer mortality, and discover novel therapeutic targets across racially and ethnically diverse populations. The program will conduct four...

The National Institute of Environmental Health Sciences (NIEHS) awarded a $1,147,169 Project Grant under the Environmental Health (CFDA 93.113) program to the Centro Comprensivo De Cancer De La Universidad De Puerto Rico. The grant, titled "The Caribbean Climate Change Adaptation, Cancer, and Health Disparities Research Center (CCCARIB-CARES)", will fund a collaborative research and capacity-building effort to assess the impact of climate change-related stressors on the cancer...

This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will provide $547,047 to Georgetown University from May 1, 2025 to April 30, 2030. The project aims to test the bundling of multicancer screening and genetic services navigation to improve cancer health equity among non-Hispanic Black and Hispanic women. The intervention will be evaluated in two community breast cancer screening navigation programs...

The National Cancer Institute (NCI) awarded a 5-year, $706,365 Cooperative Agreement (CFDA 93.393 - Cancer Cause and Prevention Research) to The Trustees of Columbia University in the City of New York to implement the WHO-endorsed "screen, triage, and treat" (ISTAR) approach for cervical cancer screening among women living with HIV in La Romana, Dominican Republic. The project aims to sustain implementation of the ISTAR approach and generate new data to inform effective and equitable...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, provides $753,446 to Boston Medical Center Corporation (BMC) to develop and evaluate an intervention to improve cervical cancer screening and follow-up rates in underserved populations. The "Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)" project aims to adapt BMC's successful HPV vaccination intervention model to...

This federal Project Grant award of $500,000 from the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) program will be used by Neighborhood Health, a Federally Qualified Health Center in Alexandria, Virginia, to increase breast and colorectal cancer screening rates among the low-income, immigrant, and uninsured patient population they serve in Northern Virginia. The two-year project, with an award period from September 1, 2024 to August 31,...